| CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies |
Globe Newswire |
04/22 |
07:30 |
| TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting |
Globe Newswire |
04/22 |
07:30 |
| Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call |
Globe Newswire |
04/22 |
07:30 |
| Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology |
Globe Newswire |
04/22 |
07:25 |
| Caliber Advances Hyatt Studios Development Platform Across Three High-Growth Markets |
Globe Newswire |
04/22 |
07:15 |
| Growscape Launches Revolutionary EarthSafe Sustainability Platform, Setting New Industry Standard |
Globe Newswire |
04/22 |
07:15 |
| Balchem Corporation Releases 2025 Sustainability Report |
Globe Newswire |
04/22 |
07:10 |
| NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs |
Globe Newswire |
04/22 |
07:00 |
| EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 |
Globe Newswire |
04/22 |
07:00 |
| Stifel Reports First Quarter 2026 Results |
Globe Newswire |
04/22 |
07:00 |
| Rogers Communications Reports First Quarter 2026 Results |
Globe Newswire |
04/22 |
07:00 |
| Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program |
Globe Newswire |
04/22 |
07:00 |
| Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| The National Gallery of Art Receives Historic $116 Million Gift from the Mitchell P. Rales Family Foundation Endowing “Across the Nation” National Lending Program |
Globe Newswire |
04/22 |
07:00 |
| Fidelity D & D Bancorp, Inc. Reports First Quarter 2026 Financial Results |
Globe Newswire |
04/22 |
07:00 |
| SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 |
Globe Newswire |
04/22 |
07:00 |
| BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs |
Globe Newswire |
04/22 |
07:00 |
| Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast |
Globe Newswire |
04/22 |
07:00 |
| Sweet Harvest Foods and Nate’s Hives Awarded Three Recipients of the Inaugural Nate’s Hives Research Grant Program |
Globe Newswire |
04/22 |
07:00 |
| Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| U.S. Retail Spending Rises in Early Spring, but Underlying Consumer Pressures Signal Caution Ahead, Reports Circana |
Globe Newswire |
04/22 |
07:00 |
| Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026 |
Globe Newswire |
04/22 |
07:00 |
| SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156 |
Globe Newswire |
04/22 |
07:00 |
| Advantage Solutions Announces Date for its First Quarter 2026 Financial Results and Conference Call |
Globe Newswire |
04/22 |
07:00 |
